Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

Clinical trial NCT06927297 · RECRUITING

Trial details

NCT number: NCT06927297
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Malignancies Advanced Solid Malignancies

Start date: 2025-05-09
Primary completion: 2026-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.